Open Access Open Access  Restricted Access Subscription Access

Treatment Challenges, Priorities, and Relationship with Healthcare Providers in HIV Care: A Cross-Sectional Survey of Portuguese Adults Living with HIV

Antonio Antunes, Ines Augusto, Patricia Parada, Chinyere Okoli, Ama Appiah, Patricia de los Rios

Abstract


BACKGROUND: The World Health Organization’s definition of health focuses on health-related quality of life in all domains, not just the “absence of disease or infirmity”. We investigated various treatment challenges among People living with HIV (PLHIV) in Portugal.

METHODS: We analyzed data for n=60 adult PLHIV with a confirmed diagnosis and on anti-retroviral therapy (ART) who participated in the 2019 Positive Perspectives Survey. Descriptive analyses were performed using R Version 3.6.1.

RESULTS: Most participants were virally suppressed (97%), male (67%); <50 years (51%); and had ≥1 non-HIV comorbidity (70%). Overall, 15% reported trouble swallowing pills, 35% experienced ART side effects, 22% felt daily oral ART limited their life, 25% were stressed by their dosing schedule, 33% said daily oral dosing cued bad memories, while 63% said daily dosing reminded them of their HIV. These challenges were associated with treatment-avoidance behaviors; PLHIV reported missing ≥1 ART dose within the past month because of food requirements 27%, side effects 12%, concerns about long-term ART impacts 10%, and problems swallowing 5%. Overall, 73% were open to taking long-acting, nondaily ART if they remained virologically controlled. Only 35% overall perceived no communication barriers with their HCPs; these individuals had higher prevalence of optimal physical (86% vs. 49%, p=0.011) and mental health (86% vs. 36%, p<0.001) than those with a perceived barrier.

CONCLUSION: For some PLHIV, taking pills daily was linked with diverse emotional challenges, including pill fatigue and anxiety. Clinicians should consider patient preferences when prescribing ART and engage PLHIV in treatment decisions.

Keywords


Clinical outcomes, emotional correlates, HIV, HIV medications, patient-physician communication, person-centered healthcare, PLHIV, Portugal, treatment adherence, unmet needs

Full Text:

PDF

References


Brown, A.E., Hayes, R., Noori, T., Azad, Y., Amato-Gauci, A.J., Pharris, A., Delpech, V.C. & The ECDC Dublin Declaration Monitoring Network (2018). HIV in Europe and Central Asia: progress in 2018 towards meeting the UNAIDS 90-90-90 targets. Euro Surveillance 23 (48) 1800622.

Bravo, P., Edwards, A., Rollnick, S. & Elwyn, G (2010). Tough decisions faced by people living with HIV: a literature review of psychosocial problems. AIDS Reviews 12 (2) 76-88.

Antori, A., Arendt, G., Becker, J.T. et al. (2007). Updated research nosology for HIV-1 associated neurocognitive disorders. Neurology 69 (18) 1789-1799.

Tross, S., Price, R.W., Navia, B., Thaler, H.T., Gold, J., Hirsch, D.A. & Sidtis, J.J. (1988). Neuropsychological characterization of the AIDS dementia complex: a preliminary report. AIDS 2 (2) 81-88.

Tan, I.L., Smith, B.R., von Geldern, G., Mateen, F.J. & McArthur, J.C. (2012). HIV-associated opportunistic infections of the CNS. The Lancet Neurology 11 (7) 605-617.

Guimarães, M.D., McKinnon, K., Campos, L.N., Melo, A.P. & Wainberg, M. (2010). HIV risk behavior of psychiatric patients with mental illness: A sample of Brazilian patients. Revista Brasileira de Psiquiatria 32, 349-360.

Meade, C.S. & Sikkema, K.J. (2005). HIV risk behavior among adults with severe mental illness: A systematic review. Clinical Psychology Review 25, 433-457.

Manji, H., Jäger, H. & Winston, A. (2013). HIV, dementia and antiretroviral drugs: 30 years of an epidemic. Journal of Neurology, Neurosurgery & Psychiatry 84 (10) 1126-1137.

HIV Justice Network and the Global Network of People Living with HIV (GNP+). Advancing HIV Justice 2: Building momentum in global advocacy against HIV criminalisation. Available at https://www.scribd.com/doc/312008825/Advancing-HIV-Justice-2-Building-momentum-in-global-advocacy-against-HIV-criminalisation. (last accessed March 20, 2020).

Smith, R., Rossetto, K. & Peterson, B.L. (2008). A meta-analysis of disclosure of one’s HIV-positive status, stigma and social support. AIDS Care 20, 1266-1275.

Stutterheim, S.E., Pryor, J.B., Bos, A.E., Hoogendijk, R., Muris, P. & Schaalma, H.P. (2009). HIV-related stigma and psychological distress: The harmful effects of specific stigma manifestations in various social settings. AIDS 23, 2353-2357.

Okoli, C., de Los Rios, P., Eremin, A., Brough, G., Young, B. & Short, D. (2020). Relationship Between Polypharmacy and Quality of Life Among People in 24 Countries Living With HIV. Preventing Chronic Disease 17, E22.

Altice, F., Evuarherhe, O., Shina, S., Carter, G. & Beaubrun, A.C. (2019). Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Preference and Adherence 13, 475-490.

Basavaraj, K.H., Navya, M.A. & Rashmi, R. (2010). Quality of life in HIV/AIDS. Indian Journal of Sexual Transmitted Diseases and AIDS 31 (2) 75-80.

de Los Rios, P., Okoli, C., Punekar, Y. et al. (2020). Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries. Preventive Medicine 139, 106182.

Lazarus, J.V., Safreed-Harmon, K., Barton, S.E. et al. (2016). Beyond viral suppression of HIV - the new quality of life frontier. BMC Medicine 14 (1) 94.

UNAIDS Data 2018. Available at: https://www.aidsdatahub.org/unaids-data-2018-unaids-2018. (last accessed March 20, 2020).

World Health Organization. Constitution. Available at: https://www.who.int/about/who-we-are/constitution. (last accessed September 19, 2019).

Buetow S.A. (1995). What do general practitioners and their patients want from general practice and are they receiving it? A framework. Social Science & Medicine 40 (2) 213-221.

Schäfer, W., Boerma, W., Schellevis, F.G. & Groenewegen, P.P. (2018). GP Practices as a One-Stop Shop: How Do Patients Perceive the Quality of Care? A Cross-Sectional Study in Thirty-Four Countries. Health Services Research 53 (4) 2047-2063.

Husain-Gambles, M., Neal, R.D., Dempsey, O., Lawlor, D.A. & Hodgson, J. (2004). Missed appointments in primary care: questionnaire and focus group study of health professionals. British Journal of General Practice 54 (499) 108-113.

October, T.W., Hinds, P.S., Wang, J., Dizon, Z.B., Cheng, Y.I. & Roter, D.L. (2016). Parent Satisfaction With Communication Is Associated With Physician's Patient-Centered Communication Patterns During Family Conferences. Pediatric Critical Care Medicine 17 (6) 490-497.

de Los Rios, P., Okoli, C., Young, B. et al. (2020). Treatment aspirations and attitudes towards innovative medications among people living with HIV in 25 countries. Population Medicine Available at: https://doi.org/10.18332/popmed/124781.

de Los Rios, P., Okoli, C., Castellanos, E. et al. (2020). Physical, emotional, and psychosocial challenges associated with daily dosing of HIV medications and their impact on indicators of quality of life: Findings from the Positive Perspectives Study. AIDS and Behavior In press.

Okoli, C., Brough, G., Allan, B., et al. (2020). Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV. AIDS and Behavior 1-12. Advance online publication. Available at: https://doi.org/10.1007/s10461-020-02973-4.

Delivering quality health services: a global imperative for universal health coverage. Geneva: World Health Organization, Organisation for Economic Co-operation and Development, and The World Bank; 2018. License: CC BY-NC-SA 3.0 IGO. Available at: http://documents.banquemondiale.org/curated/fr/482771530290792652/pdf/127816-REVISED-quality-joint-publication-July2018-Complete-vignettes-ebook-L.pdf. (last accessed March 20, 2020).

Healthcare Personnel Statistics - Physicians. Statistics Explained. Available at: https://ec.europa.eu/eurostat/statisticsexplained/. (last accessed November 29, 2019).

World Health Organization Regional Office for Europe. HIV/AIDS surveillance in Europe 2019. Available at: https://www.ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2019-2018-data. Accessed 08/09/2020.

Elwyn, G., Edwards, A., Wensing, M., Hood, K., Atwell, C. & Grol, R. (2003). Shared decision making: developing the OPTION scale for measuring patient involvement. Quality and Safety in Health Care 12 (2) 93-99.

McLeroy, K.R., Bibeau, D., Steckler, A. & Glanz, K. (1988). An Ecological Perspective on Health Promotion Programs. Health Education Quarterly 15, 351-377.

Okoli, C., Van de Velde, N., Richman, B. et al. (2020). Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries. Sexually Transmitted Infections Available at: https://doi.org/10.1136/sextrans-2020-054551.

Jordan, J., Cahn, P., Goebel, F., Matheron, S., Bradley, C. & Woodcock, A. (2005). Abacavir compared to protease inhibitors as part of HAART regimens for treatment of HIV infection: patient satisfaction and implications for adherence. AIDS Patient Care and STDs 19 (1) 9-18.

Ventura Cerda, J.M., Martin Conde, M.T., Morillo Verdugo, R., Tebenes Cortes, M. & Casado Gomez, M.A (2014). Adherence, satisfaction and health-related quality of life in HIV-infected patients with antiretroviral therapy in Spain. The ARPAS study. Farmacia hospitalaria: organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 38 (4) 291-299.

Boretzki, J., Wolf, E., Wiese, C., Noe, S., Balogh, A., Meurer, A., Krznaric, I., Zink, A., Lersch, C. & Spinner, C.D. (2017). Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study. Patient Preference and Adherence 11, 1897-1906.

Kerrigan, D., Mantsios, A., Gorgolas, M. et al. (2018). Experiences with long acting injectable ART: a qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain. PloS One 13 (1) e0190487.

Murray, M., Dorey, D., Griffith, S., Mrus, J., Spreen, W. & Margolis, D. (2016). Satisfaction, tolerability, and acceptability or cabotegravir (CAB) + rilpivirine (RPV) long-acting therapy: LATTE-2 results [abstract THPEB052]. Abstract presented at 21st International AIDS Conference (AIDS); July 18-22; Durban, South Africa.

Global AIDS Update (2020). Seizing The Moment. Tackling entrenched inequalities to end epidemics. Available at: https://www.unaids.org/en/resources/documents/2020/global-aids-report. Accessed 08/09/2020.




DOI: http://dx.doi.org/10.5750/ejpch.v8i3.1873

Refbacks

  • There are currently no refbacks.